GERN Q4 2020 Earnings — Geron Corporation Revenue & Financial Results | Market Cap Arena

GERNGeron Corporation

$1B

Q4 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$50,000-70.8% YoY

Gross Profit

-$15M-29484.0% margin

Operating Income

-$23M-46532.0% margin

Net Income

-$24M-47574.0% margin

EPS (Diluted)

$-0.07

QoQ Revenue Growth

-53.7%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$13M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$271M

Total Liabilities

$60M

Stockholders' Equity

$211M

Cash & Equivalents

$10M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$50,000	$171,000	-70.8%
Gross Profit	-$15M	-$24M	+38.5%
Operating Income	-$23M	-$30M	+22.5%
Net Income	-$24M	-$29M	+18.2%